Certain reports suggest that the recent CDC guidelines to minimize the opioid usage for chronic pain is producing more harms than good. In this regard, taking the opinions of physicians and their experiences will be helpful to weigh the benefits versus risks. Few studies suggest, the opioids have significant efficacy compared with placebo. However, these studies have small sample sizes, short durations, and potentially inadequate handling of dropouts.
Also, long-term analgesic efficacy of opioids in chronic neuropathic pain is uncertain. Opioid abuse is increasing day by day, to minimize this scenario CDC has updated the guidelines for opioid use However, the guidelines formulated by CDC have few concerns. For examples: CDC recommends that clinicians must use immediate-release (IR) opioids instead long-acting (ER/LA) opioids. But, according to experts, there is no clinical evidence…
